Carey Kernodle Anders

基本信息

浏览量：2

职业迁徙

个人简介

Dr. Carey K. Anders is an oncologist in Durham, North Carolina and is affiliated with Duke University Hospital. She has been in practice for more than 20 years. Dr. Carey K. Anders has expertise in treating breast cancer, lung cancer, among other conditions

研究兴趣

论文共 375 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract RF02-03: Trastuzumab Deruxtecan (T-Dxd) in Combination with Anastrozole or Fulvestrant in Patients with HER2-low HR+ Advanced/metastatic Breast Cancer: a Phase 1b, Open-Label, Multicenter, Dose-Expansion Study (Destiny-Breast08)

Komal Jhaveri,Fabrice André,Erika Hamilton,Peter Schmid,Carey Anders,Laura Testa,Inna Ganshina,Yen-Shen Lu,Seock-Ah Im,Robyn Young,Magdalena Wrona, Caron Lloyd, Yiwen Zhang,Sherene Loi

Cancer Researchno. 9_Supplement (2024): RF02-03

引用0浏览0引用

A Phase I Trial of Alpelisib Combined with Capecitabine in Patients with HER2-negative Metastatic Breast Cancer

Danielle M. File,Yara Abdou,Jeremy Force,Dominic T. Moore,Carey K. Anders,Katherine Reeder-Hayes,Lisa A. Carey,Hyman B. Muss,Charles M. Perou,P. Kelly Marcom,E. Claire Dees

Clinical Breast Cancer (2024)

引用0浏览0WOS引用

DESTINY-Breast07: Dose-expansion Interim Analysis of T-DXd Monotherapy and T-DXd + Pertuzumab in Patients with Previously Untreated HER2+ Mbc

Fabrice Andre,Erika P. Hamilton,Sherene Loi,Carey K. Anders,Peter Schmid,Daniil Stroyakovskiy,Rafael Villanueva,Jose Luiz Pedrini,Dinesh Chandra Doval,Bogdan Zurawski,Shin-Cheh Chen,Sarice Renee Boston,Adam Konpa, Barbara Pierotti,Giulia Fabbri,Komal L. Jhaveri

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Phase II DORA Study of Olaparib with or Without Durvalumab As a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer

Tira J. Tan,Sarah Sammons,Young-Hyuck Im,Lilin She,Kelly Mundy,Robert Bigelow,Tiffany A. Traina,Carey Anders,Joe Yeong, Ezequiel Renzulli,Sung-Bae Kim,Rebecca Dent

CLINICAL CANCER RESEARCHno. 7 (2024): 1240-1247

引用0浏览0WOS引用

Abstract PO5-20-03: Phase I/II Study of Stereotactic Radiosurgery with Concurrent Olaparib Followed by Adjuvant Durvalumab and Physician’s Choice Systemic Therapy in Subjects with Breast Cancer Brain Metastases

Colette J. Shen,Yara Abdou,Linda Chen,Xianming Tan,Gaorav P. Gupta,Mina Lobbous,Filipa Lynce,Erica Stringer-Reasor,Carey K. Anders

Cancer researchno. 9_Supplement (2024): PO5-03

引用0浏览0引用

Abstract 6472: Response to PARP Inhibitors in Patients with Breast Cancer Metastatic to the Central Nervous System

Seoho Lee,Rani Bansal,Melissa E. Hughes,Amanda E. Van Swearingen,Heather N. Moore,David O. Kamson,Solmaz Sahebjam,Greg Kirkner, Anna Gorfinkel,Sarah Sammons,Nancy U. Lin,Carey Anders,Cesar A. Santa-Maria

Cancer Researchno. 6_Supplement (2024): 6472-6472

引用0浏览0引用

Response to PARP Inhibitors in Patients with Breast Cancer Metastatic to the Central Nervous System

Seoho Lee,Rani Bansal,Melissa E. Hughes, Amanda E. Van Swearingen, Heather N. Moore, David O. Kamson, Solmaz Sahebjam, Greg Kirkner, Anna Gorfinkel,Sarah Sammons,Nancy U. Lin,Carey Anders, Cesar A. Santa-Maria

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Effect of Breast Cancer Receptor Subtypes and CSF Cytology Status on Survival for Patients with Leptomeningeal Disease